Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

• Revenue in CAD (TTM)0.00
• Net income in CAD-1.53m
• Incorporated2008
• Employees--

• Location
  Voyageur Pharmaceuticals LtdDome Tower 800, 333 7 Ave. S.W.CALGARY T2P 2Z1CanadaCAN
• Phone+1 (403) 923-5944
• Fax+1 (403) 508-2670
• Websitehttps://voyageurpharmaceuticals.ca/